Evolent Health Inc. (EVH) Trading Down 4.5%
Evolent Health Inc. (NYSE:EVH) was down 4.5% during mid-day trading on Thursday . The company traded as low as $23.76 and last traded at $23.77, with a volume of 106,759 shares traded. The stock had previously closed at $24.90.
A number of equities research analysts have issued reports on EVH shares. Canaccord Genuity reaffirmed a “buy” rating and set a $30.00 target price on shares of Evolent Health in a research report on Wednesday, July 13th. Leerink Swann reiterated a “buy” rating and set a $20.00 price target on shares of Evolent Health in a report on Monday, May 16th. Zacks Investment Research upgraded Evolent Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th. Jefferies Group initiated coverage on Evolent Health in a report on Tuesday. They set a “buy” rating and a $28.00 price target for the company. Finally, FBR & Co upped their price target on Evolent Health from $16.00 to $24.00 and gave the stock an “outperform” rating in a report on Wednesday, July 13th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $22.17.
The company’s 50-day moving average price is $19.64 and its 200 day moving average price is $13.39. The stock has a market capitalization of $1.40 billion and a price-to-earnings ratio of 6.23.
Evolent Health (NYSE:EVH) last announced its earnings results on Thursday, May 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.03. The firm earned $49.50 million during the quarter, compared to analyst estimates of $47.40 million. Evolent Health’s revenue was up 33.8% on a year-over-year basis. Equities research analysts predict that Evolent Health Inc. will post ($0.62) EPS for the current fiscal year.
A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group boosted its position in shares of Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned 0.60% of Evolent Health worth $4,310,000 as of its most recent filing with the SEC.
Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.